Stress cardiomyopathy medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:
The following interventions are done when any of these complications arise:<ref name="pmid21401402">{{cite journal |vauthors=Omerovic E |title=How to think about stress-induced cardiomyopathy?--Think "out of the box"! |journal=Scand. Cardiovasc. J. |volume=45 |issue=2 |pages=67–71 |year=2011 |pmid=21401402 |doi=10.3109/14017431.2011.565794 |url=}}</ref>
The following interventions are done when any of these complications arise:<ref name="pmid21401402">{{cite journal |vauthors=Omerovic E |title=How to think about stress-induced cardiomyopathy?--Think "out of the box"! |journal=Scand. Cardiovasc. J. |volume=45 |issue=2 |pages=67–71 |year=2011 |pmid=21401402 |doi=10.3109/14017431.2011.565794 |url=}}</ref>
*[[Cardiogenic shock]] is treated with [[intraaortic balloon pump]]
*[[Cardiogenic shock]] is treated with [[intraaortic balloon pump]]
*[[Pulomnary edema]] is treated by putting the patient in an upright position, supplementing them with [[oxygen]] and administering [[diuretics]], [[morphine]] and [[sedatives]]
*[[Pulmonary edema]] is treated by putting the patient in an upright position, supplementing them with [[oxygen]] and administering [[diuretics]], [[morphine]] and [[sedatives]]
*Heart failure is managed with heart failure drugs, such ACE inhibitors, ARBs, diuretics and [[nitrates]]


==References==
==References==

Revision as of 22:44, 6 January 2017

Stress cardiomyopathy Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stress Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy

Future or Investigational Therapies

Case Studies

Case #1

Stress cardiomyopathy medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stress cardiomyopathy medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stress cardiomyopathy medical therapy

CDC on Stress cardiomyopathy medical therapy

Stress cardiomyopathy medical therapy in the news

Blogs on Stress cardiomyopathy medical therapy

Directions to Hospitals Treating Stress cardiomyopathy

Risk calculators and risk factors for Stress cardiomyopathy medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

Medical therapy in patients with stress cardiomyopathy is mostly targeted towards the treatment of complications. For stress cardiomyopathy per se, the use of heparin and aspirin are controversial. It must be noted that the use of beta blockers alone is not advised, as this will result unopposed activity of catecholamines at the alpha receptors and further prolongation of the QT interval. The combined use of alpha- and beta blockers seems reasonable.[1]

Treatment of Complications

The following interventions are done when any of these complications arise:[1]

References

  1. 1.0 1.1 Omerovic E (2011). "How to think about stress-induced cardiomyopathy?--Think "out of the box"!". Scand. Cardiovasc. J. 45 (2): 67–71. doi:10.3109/14017431.2011.565794. PMID 21401402.

Template:WH Template:WS